Hecogenin Acetate Inhibits Reactive Oxygen Species Production and Induces Cell Cycle Arrest and Senescence in the A549 Human Lung Cancer Cell Line

Author(s): Juciano Gasparotto, Nauana Somensi, Alice Kunzler, Carolina Saibro Girardi, Matheus Augusto de Bittencourt Pasquali, Vitor Miranda Ramos, Andre Simoes-Pires, Lucindo Jose Quintans-Junior, Alexsandro Branco, Jose Claudio Fonseca Moreira, Daniel Pens Gelain

Journal Name: Anti-Cancer Agents in Medicinal Chemistry
(Formerly Current Medicinal Chemistry - Anti-Cancer Agents)

Volume 14 , Issue 8 , 2014

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Cellular and molecular mechanisms related to lung cancer have been extensively studied in recent years, but the availability of effective treatments is still scarce. Hecogenin acetate, a natural saponin presenting a wide spectrum of reported pharmacological activities, has been previously evaluated for its anticancer/antiproliferative activity in some in vivo and in vitro models. Here, we investigated the effects of hecogenin acetate in a human lung cancer cell line. A549 non-small lung cancer cells were exposed to different concentrations of hecogenin acetate and reactive species production, ERK1/2 activation, matrix metalloproteinase expression, cell cycle arrest and cell senescence parameters were evaluated. Hecogenin acetate significantly inhibited increase in intracellular reactive species production induced by H2O2. In addition, hecogenin acetate blocked ERK1/2 phosphorylation and inhibited the increase in MMP-2 caused by H2O2. Treatment with hecogenin acetate induced G0/G1-phase arrest at two concentrations (75 and 100 µM, 74% and 84.3% respectively), and increased the staining of senescence-associated β -galactosidase positive cells. These data indicate that hecogenin acetate is able to exert anti-cancer effects by modulating reactive species production, inducing cell cycle arrest and senescence and also modulating ERK1/2 phosphorylation and MMP-2 production.

Keywords: Cell cycle, ERK1/2, hecogenin acetate, non-small cell lung cancer, senescence.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Published on: 05 September, 2014
Page: [1128 - 1135]
Pages: 8
DOI: 10.2174/1871520614666140408151751
Price: $65

Article Metrics

PDF: 54